Anahtar Kelimeler
cinsel saldırı
cinsel istismar
cinsel yolla bulaşan hastalıklar
Nasıl Atıf Yapılır
Öz
Cinsel saldırı ve cinsel istismar olgularının fiziksel ve ruhsal travma ile birlikte cinsel yolla bulaşan hastalıklar (CYBH) açısından da değerlendirilmesi önemlidir. Bu olgularda muayene genellikle travma bulgularının tespiti ve saldırganın kimliğinin tespitine yönelik örnek alımı ile sınırlı olmaktadır. Cinsel yolla bulaşan Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, Hepatit B virüsü, Human immunodeficiency virüs ve sifiliz gibi çok sayıda etken mevcut olmakla birlikte ülkemizde bu etkenlere yönelik tarama testleri ve profilaksi uygulamaları ile ilgili standardize edilmiş bir rehber bulunmamaktadır. Bu nedenle, tüm olgularda bulaş riski göz önünde bulundurulmalı, gereklilik halinde tedavi ve profilaksi uygulamaları açısından değerlendirme yapılmalıdır. Ayrıca saldırgana ulaşılabildiği durumlarda gerek mağdurun CYBH için tıbbi bakım ihtiyacının belirlenebilmesi gerekse saldırganın yargılanma süreci ve illiyet bağının kurulabilmesi için bu kişilerin de muayenesi ve tetkikleri yapılmalıdır. Bu derlemede, cinsel saldırı ve cinsel istismar mağdurlarında görülebilecek cinsel yolla bulaşan hastalıkların değerlendirilmesi ve saldırganın muayenesi hususlarının, literatür bilgileri eşliğinde, adli-tıbbi yönden incelenerek sağlık çalışanlarının bu konuya dikkatlerini çekmek amaçlandı.
Referanslar
Breiding MJ, Smith SG, Basile KC, Walters ML, Chen J, Merrick MT. Prevalence and characteristics of sexual violence, stalking, and intimate partner violence victimization--national intimate partner and sexual violence survey, United States, 2011. MMWR Surveill Summ. 2014;63(8):1-18.
Argo A, Zerbo S, Triolo V, Averna L, D'Anna T, Nicosia A, et al. Legal aspects of sexually transmitted diseases: abuse, partner notification and prosecution. G Ital Dermatol Venereol. 2012;147(4):357-71.
Sexually Transmitted Diseases Treatment Guidelines, 2015. Centers for Disease Control and Prevention. MMWR. 2015/64(RR3);1-137.
Vrees RA. Evaluation and Management of Female Victims of Sexual Assault. Obstet Gynecol Surv. 2017;72(1):39-53. https://doi.org/10.1097/OGX.0000000000000390
Eliaçık K, Sürgel NA, Kanık A, Yetim A, Bolat N, Bakiler AR. Adolesan Cinsel İstismarı ile İlgili Hekimlerin Bilgi, Tutum ve Davranışları. Çocuk ve Medeniyet Dergisi. 2016;2(1):111-23
Sachs CJ, Thomas B. Sexual Assault Infectious Disease Prophylaxis. In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; https://www.ncbi.nlm.nih.gov/books/NBK482239/ [Erişim tarihi: 14 Temmuz 2019]
McConkey TE, Sole ML, Holcomb L. Assessing the female sexual assault survivor. Nurse Pract. 2001;26(7 Pt 1):28-30, 33-4, 37-9; quiz 40-1.
Jauréguy F, Chariot P, Vessières A, Picard B. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections detected by real-time PCR among individuals reporting sexual assaults in the Paris, France area. Forensic Sci Int. 2016;266:130-3. https://doi.org/10.1016/j.forsciint.2016.04.031
Lacey HB. Sexually transmitted diseases and rape: the experience of a sexual assault centre. Int J STD AIDS. 1990;1(6):405-9. https://doi.org/10.1177/095646249000100603
Jo S, Shin J, Song KJ, Kim JJ, Hwang KR, Bhally H. Prevalence and correlated factors of sexually transmitted diseases-chlamydia, Neisseria, cytomegalovirus--in female rape victims. J Sex Med. 2011;8(8):2317-26. https://doi.org/10.1111/j.1743-6109.2010.02069.x
Oshikata CT, Bedone AJ, Faúndes A. Emergency care for women following sexual assault: characteristics of women and six-month post-aggression follow-up. Cad Saude Publica. 2005;21(1):192-9. https://doi.org/10.1590/s0102-311x2005000100021
Andrianarivelo Andry M, Raherinaivo Anjatiana A, Razafindrakoto Ainamalala C, Rasoanandrasana S, Ravaoarisaina Zakasoa M, Rasamindrakotroka A. Trichomonas vaginalis among women raped in Antananarivo, 2005-2011. Med Sante Trop. 2017;27(1):109-110. https://doi.org/10.1684/mst.2014.0373
van Rooijen MS, Schim van der Loeff MF, van Kempen L, de Vries HJC. Sexually Transmitted Infection Positivity Rate and Treatment Uptake Among Female and Male Sexual Assault Victims Attending The Amsterdam STI Clinic Between 2005 and 2016. Sex Transm Dis. 2018;45(8):534-41. https://doi.org/10.1097/OLQ.0000000000000794
Sayın Kutlu S, Serinken M. Cinsel Yolla Bulaşan Hastalıklar (CYBH) İçin Acil Profilaksi Uygulamaları. JAEM. 2010;9:143-7. https://doi.org/10.4170/jaem.2010.54366
Pelit S, Bulut ME, Bayraktar B. Üretrit Semptomları Olan Erkek Hastalarda Neisseria Gonorrhoeae, Chlamydia Trachomatis, Ureaplasma Urealyticum ve Mycoplasma Hominis Sıklığının Araştırılması. Bakırköy Tıp Derg. 2017;13(1):10-3 https://doi.org/10.5350/BTDMJB201713102
Çulha G, Görür S, Helli A, Akçin S, Kiper AN. Mustafa Kemal Üniversitesi Sağlık Uygulama ve Araştırma Hastanesi Üroloji Polikliniğine Başvuran Üretritli Erkek Olgularda Trichomonas vaginalis Sıklığı. Turk Hij Den Biyol Derg. 2008;65(1):37-41.
Gökengin D, Kurtaran B, Korten V, Tabak F, Ünal S, editörler. HIV/AIDS Tanı, İzlem ve Tedavi El Kitabı, 2018.
T.C. Sağlık Bakanlığı, Bulaşıcı Hastalıkların İhbarı ve Bildirim Sistemi. Standart Tanı, Sürveyans ve Laboratuvar Rehberi. Ankara, 2004.
Australian STI Management Guidelines (Internet) Erişim linki: http://www.sti.guidelines.org.au/populations-and-situations/adult-sexual-assault [Erişim tarihi 10 Eylül 2019]
UpToDate. Bates CK. Evaluation and management of adult and adolescent sexual assault victims. (Internet) Erişim linki: https://www.uptodate.com/contents/evaluation-and-management-of-adult-and-adolescent-sexual-assault-victims [Erişim tarihi 19 Ağustos 2019]
Updated Guidelines for Antiretroviral Postexposure Prophylaxis after Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV-United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(17):458. https://doi.org/10.15585/mmwr.mm6517a5
Buzgan T, Torunoğlu MA, Gökengin D, editörler. HIV/AIDS Tanı Tedavi Rehberi, T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu, 2013. Sağlık Bakanlığı Yayın No:919
Vitale E. The forensic nursing in sexual assaults: the immunochemical diagnosis and prevention of its adverse effects. Immunopharmacol Immunotoxicol. 2012;34(2):232-43. https://doi.org/10.3109/08923973.2011.596842
Seña AC, Hsu KK, Kellogg N, Girardet R, Christian CW, Linden J, et al. Sexual Assault and Sexually Transmitted Infections in Adults, Adolescents, and Children. Clin Infect Dis. 2015;61, Suppl 8:S856-64. https://doi.org/10.1093/cid/civ786
Cybulska B. Immediate medical care after sexual assault. Best Pract Res Clin Obstet Gynaecol. 2013;27(1):141-9. https://doi.org/10.1016/j.bpobgyn.2012.08.013
Morgan L, Brittain B, Welch J. Medical care following multiple perpetrator sexual assault: a retrospective review. Int J STD AIDS. 2015;26(2):86-92. https://doi.org/10.1177/0956462414530886
Forbes KM, Day M, Vaze U, Sampson K, Forster G. Management of survivors of sexual assault within genitourinary medicine. Int J STD AIDS. 2008;19(7):482-3. https://doi.org/10.1258/ijsa.2008.008029
Ebert J, Sperhake JP, Degen O, Schröder AS. The use of HIV post-exposure prophylaxis in forensic medicine following incidents of sexual violence in Hamburg, Germany: a retrospective study. Forensic Sci Med Pathol. 2018;14(3):332-41. https://doi.org/10.1007/s12024-018-9985-7
Muriuki EM, Kimani J, Machuki Z, Kiarie J, Roxby AC. Sexual Assault and HIV Postexposure Prophylaxis at an Urban African Hospital. AIDS Patient Care STDS. 2017;31(6):255-60. https://doi.org/10.1089/apc.2016.0274
Olshen E, Hsu K, Woods ER, Harper M, Harnisch B, Samples CL. Use of human immunodeficiency virus postexposure prophylaxis in adolescent sexual assault victims. Arch Pediatr Adolesc Med. 2006;160(7):674-80. https://doi.org/10.1001/archpedi.160.7.674
Smith DK, Grohskopf LA, Black RJ, Auerbach JD, Veronese F, Struble KA, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep. 2005;54(RR-2):1-20.
Centers for Disease Control and Prevention. Vaccines and Preventable Diseases. HPV Vaccine Recommendations. (Internet) Erişim linki: https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html [Erişim tarihi 20 Temmuz 2019]
Barth J, Bermetz L, Heim E, Trelle S, Tonia T. The current prevalence of child sexual abuse worldwide: a systematic review and meta-analysis. Int J Public Health. 2013;58(3):469-83. https://doi.org/10.1007/s00038-012-0426-1
Hébert M, Amédée LM, Blais M, Gauthier-Duchesne A. Child Sexual Abuse among a Representative Sample of Quebec High School Students: Prevalence and Association with Mental Health Problems and Health-Risk Behaviors. Can J Psychiatry. 2019, Epub ahead of print. https://doi.org/10.1177/0706743719861387
UpToDate. Bechtel K, Bennett BL. Evaluation of sexual abuse in children and adolescents. (Internet) Erişim linki: https://www.uptodate.com/contents/evaluation-of-sexual-abuse-in-children-and-adolescents [Erişim tarihi 21 Temmuz 2019]
Girardet RG, Lahoti S, Howard LA, Fajman NN, Sawyer MK, Driebe EM, et al. Epidemiology of sexually transmitted infections in suspected child victims of sexual assault. Pediatrics. 2009;124(1):79-86. https://doi.org/10.1542/peds.2008-2947
Adams JA, Farst KJ, Kellogg ND. Interpretation of Medical Findings in Suspected Child Sexual Abuse: An Update for 2018. J Pediatr Adolesc Gynecol. 2018;31(3):225-31. https://doi.org/10.1016/j.jpag.2017.12.011
Leder MR, Leber AL, Marcon MJ, Scribano PV. Use of APTIMA Combo 2: the experience of a child advocacy center. J Child Sex Abus. 2013;22(3):297-311. https://doi.org/10.1080/10538712.2013.743954. In: Adams JA, Farst KJ, Kellogg ND. Interpretation of Medical Findings in Suspected Child Sexual Abuse: An Update for 2018. J Pediatr Adolesc Gynecol. 2018;31(3):225-31. https://doi.org/10.1016/j.jpag.2017.12.011
Gallion HR, Dupree LJ, Scott TA, Arnold DH. Diagnosis of Trichomonas vaginalis in female children and adolescents evaluated for possible sexual abuse: A comparison of the InPouch TV culture method and wet mount microscopy. J Pediatr Adolesc Gynecol. 2009;22(5):300-5. https://doi.org/10.1016/j.jpag.2008.12.006
Jain N. Sexually transmitted diseases in the pediatric patient. BCMJ. 2004;46(3):133-8.
Dokgöz H, Kar H. Çocukta Cinsel İstismar. Turkiye Klinikleri J Foren Med-Special Topics. 2018;4(1):8-16
Rogstad KE, Wilkinson D, Robinson A. Sexually transmitted infections in children as a marker of child sexual abuse and direction of future research. Curr Opin Infect Dis. 2016;29(1):41-4. https://doi.org/10.1097/QCO.0000000000000233
Bacopoulou F, Karakitsos P, Kottaridi C, Stefanaki C, Deligeoroglou E, Theodoridou K, et al. Genital HPV in children and adolescents: does sexual activity make a difference?. J Pediatr Adolesc Gynecol. 2016;29(3):228-33. https://doi.org/10.1016/j.jpag.2015.08.010
Unger ER, Fajman NN, Maloney EM, Onyekwuluje J, Swan DC, Howard L, et al. Anogenital human papillomavirus in sexually abused and nonabused children: a multicenter study. Pediatrics. 2011;128(3):e658-65. https://doi.org/10.1542/peds.2010-2247
Reading R, Rannan-Eliya Y. Evidence for sexual transmission of genital herpes in children. Arch Dis Child. 2007;92(7):608-13. https://doi.org/10.1136/adc.2005.086835
Jenny C, Crawford-Jakubiak JE; Committee on Child Abuse and Neglect; American Academy of Pediatrics. The evaluation of children in the primary care setting when sexual abuse is suspected. Pediatrics. 2013;132(2):e558-67. https://doi.org/10.1542/peds.2013-1741
Cosentino LA, Danby CS, Rabe LK, Macio I, Meyn LA, Wiesenfeld HC, et al. Use of Nucleic Acid Amplification Testing for Diagnosis of Extragenital Sexually Transmitted Infections. J Clin Microbiol. 2017;55(9):2801-7. https://doi.org/10.1128/JCM.00616-17
Kellogg ND, Melville JD, Lukefahr JL, Nienow SM, Russell EL. Genital and Extragenital Gonorrhea and Chlamydia in Children and Adolescents Evaluated for Sexual Abuse. Pediatr Emerg Care. 2018;34(11):761-6. https://doi.org/10.1097/PEC.0000000000001014
Lahoti SL, McClain N, Girardet R, McNeese M, Cheung K. Evaluating the Child for Sexual Abuse. Am Fam Physician. 2001;63(5):883-893.
UpToDate. Bechtel K, Bennett BL. Management and sequelae of sexual abuse in children and adolescents. (Internet) Erişim linki: https://www.uptodate.com/contents/management-and-sequelae-of-sexual-abuse-in-children-and-adolescents [Erişim tarihi 28 Temmuz 2019]
Aydın D. Neisseria gonorrhoeae, Gökengin Dereli D. Chlamydia trachomatis. Ağaçfidan A, Anğ Ö, editörler. Cinsel Temasla Bulaşan Hastalıklar. İstanbul, 1999. Sayfa: 81-5, 113-6
Karakoç E. (çeviren) Moleküler Tanı. In: Patrick Murray, Ken S. Rosenthal, Michael A. Pfaller, Editörler. Tıbbi Mikrobiyoloji. Ankara, 2010. sayfa:165-8.
Martin IM, Foreman E, Hall V, Nesbitt A, Forster G, Ison CA. Non-cultural detection and molecular genotyping of Neisseria gonorrhoeae from a piece of clothing. J Med Microbiol. 2007;56(Pt 4):487-90. https://doi.org/10.1099/jmm.0.46956-0
Sathirareuangchai S, Phuangphung P, Leelaporn A, Boon-yasidhi V. The usefulness of Neisseria gonorrhoeae strain typing by Pulse-Field Gel Electrophoresis (PFGE) and DNA detection as the forensic evidence in child sexual abuse cases: a case series. Int J Legal Med. 2015;129(1):153-7. https://doi.org/10.1007/s00414-014-1007-z
Bu çalışma Creative Commons Attribution 4.0 International License ile lisanslanmıştır.
Telif Hakkı (c) 2020 Adli Tıp Bülteni